Niki BioSolutions, Inc. (NIKI) Other Non-Current Liabilities (2018 - 2025)

Niki BioSolutions' (NIKI) quarterly Other Non-Current Liabilities came in at $3324.0 in Q4 2025, down 74.69% on a QoQ basis from $13131.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Other Non-Current Liabilities (2018 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 6 years of Other Non-Current Liabilities data on file, last reported at $3324.0 in Q4 2025.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $3324.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $3324.0 (changed N/A YoY) and the FY2025 annual result came in at $306000.0, changed N/A from the prior year.
Other Non-Current Liabilities declined to $3324.0 in Q4 2025, from $13131.0 in the prior quarter.
In the past five years, Other Non-Current Liabilities ranged from a high of $2.5 million in Q2 2023 to a low of $2266.0 in Q4 2021.
A 5-year average of $373381.8 and a median of $13131.0 in 2025 frame the typical range for Other Non-Current Liabilities.
The widest YoY moves for Other Non-Current Liabilities: up 94740.67% in 2023, down 99.29% in 2023.
Tracing NIKI's Other Non-Current Liabilities over 5 years: stood at $2266.0 in 2021, then soared by 21965.31% to $500000.0 in 2022, then slumped by 99.29% to $3558.0 in 2023, then jumped by 4383.39% to $159519.0 in 2024, then sank by 97.92% to $3324.0 in 2025.
The last three Other Non-Current Liabilities figures came in at $3324.0 (Q4 2025), $13131.0 (Q3 2025), and $176002.0 (Q2 2025), per Business Quant data.

Download Data